Class IITerminatedD-0998-2020
Drug recall · March 18, 2020
Carbidopa and Levodopa Tablets recall
Why: Product Mix-Up: A foreign tablet was found in bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01
- Lots / codes
Lot: FG11514 Exp. 05/2021
- Quantity
- 8274 100-count bottles
- Company
- Mayne Pharma Inc, Greenville, NC
- Distribution
- Distributed Nationwide in the USA
- Initiated
- March 2, 2020 · Voluntary: Firm initiated
- Classified
- March 9, 2020
- Reported
- March 18, 2020
- Ended
- October 28, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carbidopa
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.